<DOC>
<DOCNO>EP-0618225</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Linear adhesion inhibitors.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3800	A61K3800	A61P900	A61P900	A61P910	A61P2900	A61P2900	A61P3500	A61P3500	A61P4300	A61P4300	C07K100	C07K1113	C07K122	C07K700	C07K706	C07K708	C07K14435	C07K14705	C07K1478	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	C07K	C07K	C07K	C07K	C07K	C07K	C07K	C07K	C07K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K38	A61K38	A61P9	A61P9	A61P9	A61P29	A61P29	A61P35	A61P35	A61P43	A61P43	C07K1	C07K1	C07K1	C07K7	C07K7	C07K7	C07K14	C07K14	C07K14	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to linear peptides of the formula I  X-A-B-C-Arg-E-G-L-Z    I, in which A, B, C, E, G, L, X and Z have the meaning stated in Claim 1, and the salts thereof. These compounds act as integrin inhibitors and can be used in particular for the prophylaxis and treatment of circulatory disorders and in tumour therapy.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
MERCK PATENT GMBH
</APPLICANT-NAME>
<APPLICANT-NAME>
MERCK PATENT GMBH
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
DIEFENBACH BEATE
</INVENTOR-NAME>
<INVENTOR-NAME>
FELDING-HABERMANN BRUNHILDE DR
</INVENTOR-NAME>
<INVENTOR-NAME>
JONCZYK ALFRED DR
</INVENTOR-NAME>
<INVENTOR-NAME>
DIEFENBACH, BEATE
</INVENTOR-NAME>
<INVENTOR-NAME>
FELDING-HABERMANN, BRUNHILDE, DR., C/O BFH PROGRAM
</INVENTOR-NAME>
<INVENTOR-NAME>
JONCZYK, ALFRED, DR.
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
